Can sildenafil treat primary premature ejaculation? A prospective clinical study
Background: Recently, sildenafil has been demonstrated to be effective in treating premature ejaculation (PE). However, these studies ignored female factors and could not exclude the probability of drug interaction when combined with paroxetine. Therefore, the aim of this study was to evaluate the efficacy and safety of sildenafil alone in the treatment of primary PE, taking female factors into consideration.
Methods: One hundred and eighty potent men with primary PE were randomly divided into three groups and followed up for 6 months. Group A were treated with 50 mg sildenafil as needed, group B with 20 mg paroxetine daily and group C with squeeze technique daily. Intravaginal ejaculatory latency time (IELT), PE grade, intercourse satisfactory score (ISS), frequency of intercourse, and adverse effects of drugs were recorded before treatment, and 3 and 6 months after treatment.
Results: Compared with pretreatment, the three groups had significant differences in all the parameters after 3 or 6 months treatment, except the frequency of intercourse in Group C (all P = 0.00). However, there were no significant differences between 3 and 6 months. Compared with paroxetine and squeeze technique, after 3 or 6 months, sildenafil had significant differences in all the parameters (all P = 0.00). After 6 months, 1.7%, 18.3% and 36.7% patients in groups A, B and C, respectively, withdrew from the study and 86.7%, 60.0% and 45.0% patients, respectively, wanted to be treated further with the original administration, and this was statistically significant (both P = 0.00).
Conclusion: Sildenafil is very effective and safe to treat PE, and has much higher efficacy than paroxetine and squeeze technique.
Similar articles
Salonia A, Maga T, Colombo R, Scattoni V, Briganti A, Cestari A, Guazzoni G, Rigatti P, Montorsi F. Salonia A, et al. J Urol. 2002 Dec;168(6):2486-9. doi: 10.1016/S0022-5347(05)64174-2. J Urol. 2002. PMID: 12441946
Chen J, Mabjeesh NJ, Matzkin H, Greenstein A. Chen J, et al. Urology. 2003 Jan;61(1):197-200. doi: 10.1016/s0090-4295(02)02075-7. Urology. 2003. PMID: 12559295
Hosseini MM, Yarmohammadi H. Hosseini MM, et al. Urol Int. 2007;79(1):28-32. doi: 10.1159/000102909. Urol Int. 2007. PMID: 17627164 Clinical Trial.
Chen J, Keren-Paz G, Bar-Yosef Y, Matzkin H. Chen J, et al. Eur Urol. 2007 Nov;52(5):1331-9. doi: 10.1016/j.eururo.2007.08.005. Epub 2007 Aug 17. Eur Urol. 2007. PMID: 17728050 Review.
Wang WF, Chang L, Minhas S, Ralph DJ. Wang WF, et al. Chin Med J (Engl). 2007 Jun 5;120(11):1000-6. Chin Med J (Engl). 2007. PMID: 17624269 Review.
Cited by
Saleh R, Majzoub A, Abu El-Hamd M. Saleh R, et al. Arab J Urol. 2021 Aug 4;19(3):281-302. doi: 10.1080/2090598X.2021.1943273. eCollection 2021. Arab J Urol. 2021. PMID: 34552780 Free PMC article. Review.
Zhang D, Cheng Y, Wu K, Ma Q, Jiang J, Yan Z. Zhang D, et al. BMC Urol. 2019 Jan 3;19(1):2. doi: 10.1186/s12894-018-0431-7. BMC Urol. 2019. PMID: 30606186 Free PMC article.
Jian Z, Wei X, Ye D, Li H, Wang K. Jian Z, et al. Int Urol Nephrol. 2018 Nov;50(11):1939-1948. doi: 10.1007/s11255-018-1984-9. Epub 2018 Sep 17. Int Urol Nephrol. 2018. PMID: 30225547
Mohamed MA, Atty SA, Yehia AM, Foster CW, Banks CE, Allam NK. Mohamed MA, et al. ACS Omega. 2017 Oct 31;2(10):6628-6635. doi: 10.1021/acsomega.7b01193. Epub 2017 Oct 11. ACS Omega. 2017. PMID: 30023526 Free PMC article.
Sun Y, Yang L, Bao Y, Liu Z, Liu L, Wei Q. Sun Y, et al. World J Urol. 2017 Dec;35(12):1817-1831. doi: 10.1007/s00345-017-2086-5. Epub 2017 Sep 14. World J Urol. 2017. PMID: 28913588 Review.
